Shandong Anhong Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CILASTATIN SODIUM, with a corresponding US DMF Number 42234.
Remarkably, this DMF maintains an Active status since its submission on July 07, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 10, 2025, and payment made on July 03, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II